Clinical Trials for RGT-61159 | Rgenta Therapeutics Inc. | Boston, MA Join Rgenta's Phase 1a/b trial for RGT-61159, targeting advanced cancers. Contact us to learn about innovative treatment options.

eg.

Erlotinib ( #FOXA2; EGFR-TKIs)
RGT-61159 ( #MYB) www.rgentatx.com/clinical-tri...
Romidepsin ( #HDACi; #HDAC2)